Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Chief Medical Information Off | April 02, 2022 | August 02, 2022 |
| Professional Holding Corp.PFHD · Entity 121209 | Director | December 20, 2022 | December 30, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date April 02, 2022 · Filed August 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 263,444 |
Ending reported balance
After 2022-04-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-02 · Conversion · Acquired 19,597 · Balance 253,645 Row 2 · 2022-04-02 · Other · Acquired 9,799 · Balance 263,444 |
| Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $1.55 · Expires 2022-07-31 | Direct | 0 |
Reported balance
After 2022-04-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-04-02 · Conversion · Disposed 30,375.35 · Balance 0 F1: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.55 · Expires 2022-07-31 | Direct | 0 |
Reported balance
After 2022-04-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-02 · Other · Disposed 9,799 · Balance 0 F2: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
F2: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
Professional Holding Corp.
Report date December 20, 2022 · Filed December 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A CommonSEC Table I · non-derivative | Direct | 43,831 |
Reported balance
After 2022-12-20 transaction · row 1
1 source rowRow 1 · 2022-12-20 · Grant · Acquired 3,848 · Balance 43,831 F1: This amount represents 3,848 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Directors' compensation. The grant vests in three annual installments December 20, 2023, December 20, 2024, and December 20, 2025, subject to earlier vesting in certain circumstances. The closing market price of a share of Class A Common Stock on the date of the grant was $27.67. |
| Class A CommonSEC Table I · non-derivative | IndirectLawrence Schimmel IRA | 30,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount represents 3,848 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Directors' compensation. The grant vests in three annual installments December 20, 2023, December 20, 2024, and December 20, 2025, subject to earlier vesting in certain circumstances. The closing market price of a share of Class A Common Stock on the date of the grant was $27.67.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2022 Filed Dec 30, 2022 14:52 UTC | Professional Holding Corp. PFHD · Entity 121209 | GrantClass A Common | 3,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001630856-22-000102 · wf-form4_167242992578408.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,831 F1 · price: This amount represents 3,848 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Directors' compensation. The grant vests in three annual installments December 20, 2023, December 20, 2024, and December 20, 2025, subject to earlier vesting in certain circumstances. The closing market price of a share of Class A Common Stock on the date of the grant was $27.67. Read SEC document |
| August 08, 2022 Filed Aug 8, 2022 17:45 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common · Derivative | 2,500 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001925649-22-000008 · wf-form4_165999511148614.xml · derivative · entry 5 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common · 2,500 shares Expires 2023-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Options (right to buy) Read SEC document |
| August 08, 2022 Filed Aug 8, 2022 17:45 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common · Derivative | 4,500 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001925649-22-000008 · wf-form4_165999511148614.xml · derivative · entry 4 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common · 4,500 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Options (right to buy) Read SEC document |
| August 08, 2022 Filed Aug 8, 2022 17:45 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common | 2,500 | $12.50 | $31,250.00 |
DisclosureSEC source: 0001925649-22-000008 · wf-form4_165999511148614.xml · nonDerivative · entry 2 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise of an option that was due to expire on October 1, 2023. Read SEC document |
| August 08, 2022 Filed Aug 8, 2022 17:45 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common | 4,500 | $12.50 | $56,250.00 |
DisclosureSEC source: 0001925649-22-000008 · wf-form4_165999511148614.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of an option that was due to expire on January 1, 2023. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 18:24 UTC | Professional Holding Corp. PFHD · Entity 121209 | GrantClass A Common | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001925649-22-000004 · wf-form4_165965182589333.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,947 F1 · price: This amount represents 4,410 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan. The grant vests in three annual installments commencing August 1, 2022. The closing market price on the date of the grant was $22.68 Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC | Nutex Health Inc. NUTX · Entity 4803 | OtherWarrant · Derivative | 9,799 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · derivative · entry 4 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,799 shares Expires 2022-07-31 F2 · security: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F2 · derivative.exercise_price: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F2 · derivative.expiration_date: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC | Nutex Health Inc. NUTX · Entity 4803 | ConversionConvertible Promissory Note · Derivative | 30,375.35 | $100,000.00 Strike: $1.55 | $3,037,535,000.00 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · derivative · entry 3 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,597 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F1 · derivative.exercise_price: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F1 · derivative.expiration_date: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC | Nutex Health Inc. NUTX · Entity 4803 | OtherCommon Stock | 9,799 | $1.55 | $15,188.45 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · nonDerivative · entry 2 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,444 Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC | Nutex Health Inc. NUTX · Entity 4803 | ConversionCommon Stock | 19,597 | $1.55 | $30,375.35 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:34 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantOfficer Stock Option (right to buy) · Derivative | 200,000 | $2.75 Strike: $200,000.00 | $550,000.00 |
DisclosureSEC source: 0001486189-22-000006 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,684 Underlying: Common Stock · 200,000 shares Expires 2032-04-01 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 17:27 UTC | Professional Holding Corp. PFHD · Entity 121209 | SaleClass A Common | 1,312 | $21.50 | $28,208.00 |
DisclosureSEC source: 0001630856-22-000041 · wf-form4_164755242089354.xml · nonDerivative · entry 2 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,537 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 17:27 UTC | Professional Holding Corp. PFHD · Entity 121209 | SaleClass A Common | 925 | $21.07 | $19,489.75 |
DisclosureSEC source: 0001630856-22-000041 · wf-form4_164755242089354.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,849 Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:21 UTC | Professional Holding Corp. PFHD · Entity 121209 | GrantClass A Common | 3,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001630856-22-000034 · wf-form4_164384047967463.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,774 F1 · price: This amount represents 3,848 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Directors' compensation. The grant vests in three annual installments January 3, 2023, January 3, 2024, and January 3, 2025. The closing market price of a share of Class A Common Stock on the date of the grant was $20.27. Read SEC document |
| December 17, 2021 Filed Dec 17, 2021 17:26 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common · Derivative | 2,500 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001630856-21-000027 · wf-form4_163977999639210.xml · derivative · entry 3 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Class A Common · 2,500 shares Expires 2021-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock Options (right to buy) Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 17:26 UTC | Professional Holding Corp. PFHD · Entity 121209 | Exercise / conversionClass A Common | 2,500 | $13.00 | $32,500.00 |
DisclosureSEC source: 0001630856-21-000027 · wf-form4_163977999639210.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of an option that was due to expire on December 31, 2021. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 15:52 UTC | Professional Holding Corp. PFHD · Entity 121209 | SaleClass A Common | 1,102 | $18.90 | $20,827.80 |
DisclosureSEC source: 0001630856-21-000025 · wf-form4_163968793877471.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,426 Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 09:37 UTC | Professional Holding Corp. PFHD · Entity 121209 | SaleClass A Common | 150 | $19.88 | $2,982.00 |
DisclosureSEC source: 0001630856-21-000019 · wf-form4_163776463720447.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,528 Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 18:09 UTC | Professional Holding Corp. PFHD · Entity 121209 | SaleClass A Common Stock | 300 | $17.98 | $5,394.00 |
DisclosureSEC source: 0001104659-21-033909 · tm219164d1_4seq1.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,714 F1 · shares: This amount represents 300 shares of Class A Common Stock sold for estate planning purposes. Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 19:49 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantCommon Stock | 107,692 | $0.65 | $69,999.80 |
DisclosureSEC source: 0001486189-21-000003 · primary_doc.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,047 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:18 UTC | Professional Holding Corp. PFHD · Entity 121209 | GrantClass A Common Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001733 · tm211862d8_4.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,014 F1 · shares: This amount represents 4,105 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Director's Compensation. The grant vests in three annual installments commencing January 4, 2021. The closing market price on the date of the grant was $15.22. F1 · price: This amount represents 4,105 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan for Director's Compensation. The grant vests in three annual installments commencing January 4, 2021. The closing market price on the date of the grant was $15.22. Read SEC document |
| June 30, 2020 Filed Sep 9, 2020 13:41 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseCommon Stock | 44,828 | $65,000.00 | $2,913,820,000.00 |
DisclosureSEC source: 0001486189-20-000016 · primary_doc.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,355 F1 · balance_after: Does not include 36,288 options to purchase common shares, 5,465 convertible options and 3,415 warrants previously reported. Read SEC document |
| May 27, 2020 Filed May 29, 2020 18:07 UTC | Professional Holding Corp. PFHD · Entity 121209 | GrantClass A Common Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-067896 · tm2021194-5_4.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,909 F1 · shares: This amount represents 3,579 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan. The grant vests in three annual installments commencing December 31, 2020. The closing market price on the date of the grant was $15.29. F1 · price: This amount represents 3,579 shares of restricted Class A Common Stock granted and issued under Professional Holding Corp.'s 2019 Equity Incentive Plan. The grant vests in three annual installments commencing December 31, 2020. The closing market price on the date of the grant was $15.29. Read SEC document |
| May 11, 2020 Filed Jun 18, 2020 14:13 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantOfficer Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000008 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,168 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:38 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantOfficer Stock Option (right to buy) · Derivative | 6,288 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793716-20-000001 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,288 Underlying: Common Stock · 6,288 shares Expires 2030-01-27 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.